Australian (ASX) Stock Market Forum

IBA - IBA Health

Status
Not open for further replies.
Porper said:
Still not popular with ASF members but IBA has performed brilliantly in the past few months.

Having a fairly major...ish retracement at the moment.

I find the daily chart difficult to label, but it seems that wave 5 has completed and we are in wave A of an A, B, C correction which could take us down to around $1.18 in theory but in this market maybe we won't get that far.

I think it is a great stock to trade using Elliot wave an Fib and when .............if we get a decent retracement there could be another potential great trade coming up.

Any positive criticism , thoughts welcome.

Agree although I don't think it will go below 1.28...the last major support/resistance level. I think at these levels or anything below is a good accumulate levels IMO.
 
with the China deal announced yesterday, Iba has hit new high of 1.615 today currently trading around the 1.60 mark.
 
mpv said:
with the China deal announced yesterday, Iba has hit new high of 1.615 today currently trading around the 1.60 mark.

Its a good growth stock, not much more to say except keep going son!!!
 
SP has been spectacular this week, however following the ASX ann below today the SP has dropped 10.5 cents this morning
IBA $1.52 -$0.105 -6.46% 1,750,866 $2,711,406 16-Feb 10:33:42

ASX ann today
Statement regarding recent press speculation
http://www.asx.com.au/asx/statistics/showAnnouncementPDF.do?idsID=00693765

Sydney – 16 February 2007 - Following recent press speculation, IBA Health Limited (ASX- IBA) confirms that it is in discussions with iSOFT Group plc (the "Company"), which may or may not lead to an all-share recommended offer for the Company being made by IBA Health. IBA Health also confirms that it is in discussions with certain financial institutions to obtain the funding which would be required should an offer for the Company be made by IBA Health. This funding would refinance the Company’s existing debt facilities
and provide adequate working capital for the ongoing requirements of the enlarged group.
 
bigdog said:
SP has been spectacular this week, however following the ASX ann below today the SP has dropped 10.5 cents this morning
IBA $1.52 -$0.105 -6.46% 1,750,866 $2,711,406 16-Feb 10:33:42

ASX ann today
Statement regarding recent press speculation
http://www.asx.com.au/asx/statistics/showAnnouncementPDF.do?idsID=00693765

Sydney – 16 February 2007 - Following recent press speculation, IBA Health Limited (ASX- IBA) confirms that it is in discussions with iSOFT Group plc (the "Company"), which may or may not lead to an all-share recommended offer for the Company being made by IBA Health. IBA Health also confirms that it is in discussions with certain financial institutions to obtain the funding which would be required should an offer for the Company be made by IBA Health. This funding would refinance the Company’s existing debt facilities
and provide adequate working capital for the ongoing requirements of the enlarged group.

I see this as a positive if the deal comes off due to the new markets IBA will enter. In the meantime however there will be pressure on the SP as there is talk of raising funds and isoft is having troubles at the moment so IBA will need to use its expertise to turn the business around.
 
Todays SMH and IBA shares are suspended until next Monday

The SP could go in either direction come Monday!

http://www.smh.com.au/news/business...-to-chase-isoft/2007/05/08/1178390304514.html

IBA Healthcare ready to chase iSoft
May 9, 2007

LONDON: Australian IT group IBA Healthcare is reportedly expected to launch a £132.3 million ($317.9 million) all-share bid for embattled National Health Service software services company iSoft.

Shareholders of iSoft would be offered 1.1 new IBA shares for each iSoft share, valuing the British company at $1.38 a share, The Times newspaper has reported.

Shares in iSoft closed at 48p on Friday before Monday's UK bank holiday.

IBA shares were frozen to enable the group to hold meetings with institutional investors with a view to raising $200 million of new equity to help fund the acquisition of iSoft.

The new equity is expected to be raised through an institutional placement and a rights issue to existing shareholders.

That funding is supported by $315 million in new debt facilities underwritten by ABN Amro, which has been secured subject to the completion of IBA's equity raising.
 
ASX announcements today

SP today down 4.5 cents after ANN

Code Last Move % Move Buyers Sellers Open --High --Low --Volume ---Value -----Last Traded
IBA $1.21 -$0.045 -3.59 $1.205 $1.21 $1.225 $1.225 $1.165 5,249,828 6,319,628 16-May 10:42:14

IBA 9:40 AM Recommended Offer to acquire iSOFT for $333m/Capital Raising
http://asx.com.au/asx/statistics/showAnnouncementPDF.do?idsID=00721417
IBA announces A$333 million recommended offer for iSOFT creating
one of the world's largest eHealth companies


16 May 2007 – IBA Health Limited (ASX: IBA) (“IBA”), Australia's largest listed eHealth company, today announced that IBA and the board of iSOFT Group plc (LSE: IOT) (“iSOFT”) have reached agreement on the terms of a recommended all-share offer under which IBA will acquire the entire ordinary share capital of iSOFT, creating one of the world's largest healthcare information systems providers.

Under the terms of the offer, to be effected by a scheme of arrangement, iSOFT shareholders will be entitled to receive 1.1 new IBA shares for each iSOFT share, valuing each iSOFT share at A$1.38 (58.1 pence) and iSOFT’s equity capital at approximately A$333 million (£140 million).

IBA also announced today that:
it has successfully launched and allocated a A$54.5 million conditional placement of 51.9 million IBA shares at an issue price of A$1.05, which was over-subscribed by a range of international and domestic institutions;

a A$145.4 million renounceable rights issue offering IBA shareholders 2 new IBA shares at a price of A$1.05 per share for every 5 shares they own at 24 May 2007 has been fully underwritten by ABN AMRO Rothschild; and

ABN AMRO has agreed to provide to IBA new debt facilities of £130 million (A$309 million), subject to satisfying a number of conditions.

IBA 10:19 AM Prospectus - Renounceable Rights Issue
http://asx.com.au/asx/statistics/showAnnouncementPDF.do?idsID=00721452

IBA 10:50 AM Roadshow Investor Presentation
http://asx.com.au/asx/statistics/showAnnouncementPDF.do?idsID=00721473
 
I am really happy to take right issue. I am looking long term value for IBA. It will cross $2 by next year bcoz they got really good management team and i am sure they will turn around iSoft.
 
tdkx669 said:
I am really happy to take right issue. I am looking long term value for IBA. It will cross $2 by next year bcoz they got really good management team and i am sure they will turn around iSoft.

Agreed. I'll be taking the issue also. The merger with isoft will really turn this company into a global player. All they need to do now is add a US division and they would be primed for some pretty impressive growth. Definetly a long term keeper IMO.
 
Me three,
I'll be taking up the Rights Issue for sure, and if Mr Market complies on price will look to top up further.
 
Hi all, just some more info on IBA. I had an unrelated meeting this morning with one of the Perth based companies that is using IBA's products. It may or may not be relevant, but a complete roll out of patient/client management software with hand held devices to 1500+ care/nursing staff is due to be completed in 6-12 months.

This company is the largest community care provider in WA, and is industry leading in many areas. I would be very suprised if most of the smaller community care providers didn't follow suit.
 
Announced a trading halt this morning, potential shiit fight brewing over the acquisition of iSOFT.

Might make some of the refinancing interesting too.
 
today has been advised by iSOFT Group plc (“iSOFT”) that it has received a letter from CSC Computer
Sciences Limited (“CSC”) advising that CSC will not provide its consent to the change of control in iSOFT,
which would result from the completion of the Recommended All Share Offer to be effected by a Scheme
of Arrangement under which a wholly owned subsidiary of IBA Health Limited (“IBA”) will acquire the
entire issued and to be issued share capital of iSOFT.
CSC has not provided any reasons regarding this position and both iSOFT and IBA are now seeking
clarification from CSC regarding this matter.
Both iSOFT and IBA are considering their respective positions and a further announcement will be made
before trading in IBA shares resume...
 
http://www.theage.com.au/news/busin...r/2007/07/23/1185043032088.html?page=fullpage

Trumped IBA Health thinks it overJuly 24, 2007

HEALTH care software provider IBA Health's proposed $333 million merger with British counterpart iSOFT Group plc appears to have been derailed by an eleventh-hour counter-bid from CompuGROUP UK Ltd.

IBA said yesterday that iSOFT directors had withdrawn their support for the IBA offer and had agreed to a cash offer from CompuGROUP.


The directors of iSOFT have said they will seek adjournment of a court hearing to sanction a scheme of arrangement with IBA that was scheduled for tomorrow.

IBA executive chairman Gary Cohen said iSOFT shareholders had voted less than two weeks ago to adopt IBA's offer and IBA remained convinced its offer was superior on a merged valuation basis. "In light of this, IBA is considering the options available and will make a further announcement in due course," he said.

Mr Cohen said the cash bid by CompuGROUP and its acceptance by iSOFT directors was surprising.

iSOFT intends to terminate the implementation agreement with IBA, which will trigger an obligation on iSOFT to pay IBA and inducement fee of $3.25 million.

iSOFT said on Friday that the offer from CompuGROUP would be carried out by a scheme of arrangement.

CompuGROUP is offering 66p in cash for each iSOFT share, valuing iSOFT at about £160 million ($A374 million).

iSOFT said CompuGROUP UK, a subsidiary of Frankfurt-listed e-health company CompuGROUP Holding AG, was a newly incorporated company formed for the purpose of implementing the scheme of arrangement.

IBA had said that the merger of IBA and iSOFT would create one of the world's largest providers of health care information technology.
 
ASX announcement today

(profit just exceeds - but revenue much better!!)

25/07/2007 IBA profit exceeds latest FY2007 guidance
http://www.asx.com.au/asx/statistics/showAnnouncementPDF.do?idsID=00741724

IBA profit exceeds latest FY2007 guidance
Sydney – Wednesday, 25 July 2007 – IBA Health Limited (ASX: IBA)

Australia's largest listed eHealth company today advised that the profit before tax and amortisation (PBTA) for the year ending 30 June 2007 will be in the range of $31 – $31.5 million, compared with guidance of $30.7 million in February 2007 and PBTA of $18.1 million in FY2006. Revenue will be in the range of $74 – $75 million (FY2006 $59 million).

This result excludes one–off costs relating to the iSOFT acquisition, which to date have totalled $3.3 million net of the agreed break fee, payable if the acquisition does not proceed. These costs have been limited by an early decision to structure advisory fees for the deal on a success fee basis.
 
This stock is annoying me quite a bit (to put it nicely) They make a takeover offer for isoft, and the price gets hammered, the takeover looks like its not going to proceed, and the stock gets hammered again. Doesn't make any sense to me :confused:
 
i agree about being annoyed - in fact i have been wanting to sell it just to avoid the bizarre ups and downs. the rally today was interesting but there are obviously some big institutional sellers around who do not like the potential of this stock???/ i suspect that if they go back to isoft with a different bid it will cost lots more and this will impact share price once again???? it seems that 1.02 is support and so we might see things go back to that level. i think this one requires commitment to the company - something that i do not think i am interested in anymore??? any thoughts from anyone else?
 
IBA share price has been dropping every day!

Today IBA $0.87 -$0.03 -3.33% high of $0.91 2,361,146 shares; $2,099,362 @ 13-Aug 14:45:35

A big drop over the past three weeks!

Date Close Volume
10-Aug-07 0.90 3,087,205
09-Aug-07 0.95 2,242,438
08-Aug-07 0.95 2,634,953
07-Aug-07 0.97 1,933,517
06-Aug-07 0.96 1,543,248
03-Aug-07 1.00 1,861,298
02-Aug-07 0.97 3,954,683
01-Aug-07 1.02 2,767,782
31-Jul-07 1.05 2,020,192
30-Jul-07 1.02 2,595,812
27-Jul-07 1.05 4,189,307
26-Jul-07 1.09 2,624,760
25-Jul-07 1.11 4,125,410
24-Jul-07 1.11 5,907,307
23-Jul-07 1.13 8,523,397
20-Jul-07 1.22 1,532,342
 
ASX ann on higher iSoft offer yesterday and covered by attached press in AGE today

http://www.theage.com.au/news/busin...t/2007/08/22/1187462353226.html?page=fullpage
IBA Health plays hardball on iSoft

Garry Barker
August 23, 2007

IBA Health, Australia's largest listed e-health company, has raised its cash bid for British e-health software group iSoft to £166.3 million ($A410.7 million) and expects to beat off German rival bidder CompuGroup.

The acquisition, if successful, would make IBA the world's fourth-largest e-health group and the largest outside the US.

IBA already holds more than 24 per cent of iSoft, which, IBA executive chairman Gary Cohen said from London yesterday, gave his bid a significant edge. He expected a decision in IBA's favour within two weeks.

CompuGroup had earlier trumped IBA's initial bid with an all-cash offer of £160 million, or 66 pence a share.

IBA's new offer has a scrip alternative; either 69p cash per share or 1.65 IBA shares for every iSoft share, or a combination of both.

The scrip alternative represents an implied offer of 70.2p per share, based on IBA's share price of 92 ¢ on August 21.

IBA's bid has been supported by Allco Equity Partners, which will make a cornerstone investment in IBA of up to $300 million on completion of the revised offer.

AEP managing director Marcus Derwin said the proposed investment in IBA suited AEP's investment mandate. AEP was attracted to the growth potential of the global health-care IT sector and a combination of IBA and iSOFT was "a compelling investment proposition".

In Australia, IBA transmits financial and clinical data to general, specialist and allied health professionals, Medicare and private health funds, and provides health services to more than 5000 primary care providers, 300 aged and community care facilities, 50 per cent of private hospitals, public hospitals and the Australian Defence Force.

Combined with iSoft, IBA will have a worldwide client list of 13,000, Mr Cohen said.

He said the combination of IBA and iSOFT was expected to increase significantly IBA's 2008 earnings per share before amortisation of acquisition-related intangibles and save $27 million in costs by 2009.

IBA shares, which last Thursday had sales as low as 76.5 ¢, continued their advance, rising 8 ¢ to $1.

http://www.ibatech.com
 
Status
Not open for further replies.
Top